{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:37:04Z","timestamp":1794109024593,"version":"4.8.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 854"],"award-info":[{"award-number":["SFB 854"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12974-019-1539-8","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T03:41:57Z","timestamp":1564371717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Neuronal impairment following chronic Toxoplasma gondii infection is aggravated by intestinal nematode challenge in an IFN-\u03b3-dependent manner"],"prefix":"10.1186","volume":"16","author":[{"given":"Timothy","family":"French","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning Peter","family":"D\u00fcsedau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aindrila","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norus","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sch\u00fcler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn H.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildiko Rita","family":"Dunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"key":"1539_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.brainresrev.2004.12.008","volume":"48","author":"JJA Hendriks","year":"2005","unstructured":"Hendriks JJA, Teunissen CE, de Vries HE, Dijkstra CD. Macrophages and neurodegeneration. Brain Res Brain Res Rev. 2005;48:185\u201395. \n                              https:\/\/doi.org\/10.1016\/j.brainresrev.2004.12.008\n                              \n                           .","journal-title":"Brain Res Brain Res Rev"},{"key":"1539_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/jcbfm.2012.153","volume":"33","author":"LL Muldoon","year":"2013","unstructured":"Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, et al. Immunologic privilege in the central nervous system and the blood-brain barrier. J Cereb Blood Flow Metab. 2013;33:13\u201321. \n                              https:\/\/doi.org\/10.1038\/jcbfm.2012.153\n                              \n                           .","journal-title":"J Cereb Blood Flow Metab"},{"key":"1539_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nm0502-509","volume":"8","author":"MC Levin","year":"2002","unstructured":"Levin MC, Lee SM, Kalume F, Morcos Y, Jr FCD, Hasty KA, et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med. 2002;8:509. \n                              https:\/\/doi.org\/10.1038\/nm0502-509\n                              \n                           .","journal-title":"Nat Med"},{"key":"1539_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/embj.201386609","volume":"33","author":"M Schwartz","year":"2014","unstructured":"Schwartz M, Baruch K. The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J. 2014;33:7\u201322. \n                              https:\/\/doi.org\/10.1002\/embj.201386609\n                              \n                           .","journal-title":"EMBO J"},{"key":"1539_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1084\/jem.20180199","volume":"216","author":"GT Norris","year":"2019","unstructured":"Norris GT, Kipnis J. Immune cells and CNS physiology: microglia and beyond. J Exp Med. 2019;216:60\u201370. \n                              https:\/\/doi.org\/10.1084\/jem.20180199\n                              \n                           .","journal-title":"J Exp Med"},{"key":"1539_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature18626","volume":"535","author":"AJ Filiano","year":"2016","unstructured":"Filiano AJ, Xu Y, Tustison NJ, Marsh RL, Baker W, Smirnov I, et al. Unexpected role of interferon-\u03b3 in regulating neuronal connectivity and social behaviour. Nature. 2016;535:425. \n                              https:\/\/doi.org\/10.1038\/nature18626\n                              \n                           .","journal-title":"Nature"},{"key":"1539_CR7","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1007\/s12035-016-9988-x","volume":"54","author":"A Stojakovic","year":"2017","unstructured":"Stojakovic A, Paz-Filho G, Arcos-Burgos M, Licinio J, Wong M-L, Mastronardi CA. Role of the IL-1 pathway in dopaminergic neurodegeneration and decreased voluntary movement. Mol Neurobiol. 2017;54:4486\u201395. \n                              https:\/\/doi.org\/10.1007\/s12035-016-9988-x\n                              \n                           .","journal-title":"Mol Neurobiol"},{"key":"1539_CR8","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.cell.2015.11.023","volume":"163","author":"S Habbas","year":"2015","unstructured":"Habbas S, Santello M, Becker D, Stubbe H, Zappia G, Liaudet N, et al. Neuroinflammatory TNF\u03b1 impairs memory via astrocyte signaling. Cell. 2015;163:1730\u201341. \n                              https:\/\/doi.org\/10.1016\/j.cell.2015.11.023\n                              \n                           .","journal-title":"Cell"},{"key":"1539_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1084\/jem.20091419","volume":"207","author":"NC Derecki","year":"2010","unstructured":"Derecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A, Lynch KR, Kipnis J. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med. 2010;207:1067\u201380. \n                              https:\/\/doi.org\/10.1084\/jem.20091419\n                              \n                           .","journal-title":"J Exp Med"},{"key":"1539_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.mcn.2003.10.023","volume":"25","author":"SA Kuhn","year":"2004","unstructured":"Kuhn SA, van Landeghem FKH, Zacharias R, F\u00e4rber K, Rappert A, Pavlovic S, et al. Microglia express GABA(B) receptors to modulate interleukin release. Mol Cell Neurosci. 2004;25:312\u201322. \n                              https:\/\/doi.org\/10.1016\/j.mcn.2003.10.023\n                              \n                           .","journal-title":"Mol Cell Neurosci"},{"key":"1539_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.mcn.2005.01.003","volume":"29","author":"K F\u00e4rber","year":"2005","unstructured":"F\u00e4rber K, Pannasch U, Kettenmann H. Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol Cell Neurosci. 2005;29:128\u201338. \n                              https:\/\/doi.org\/10.1016\/j.mcn.2005.01.003\n                              \n                           .","journal-title":"Mol Cell Neurosci"},{"key":"1539_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fcimb.2019.00073","volume":"9","author":"AK Bhandage","year":"2019","unstructured":"Bhandage AK, Kanatani S, Barragan A. Toxoplasma-induced hypermigration of primary cortical microglia implicates GABAergic signaling. Front Cell Infect Microbiol. 2019;9:73. \n                              https:\/\/doi.org\/10.3389\/fcimb.2019.00073\n                              \n                           .","journal-title":"Front Cell Infect Microbiol"},{"key":"1539_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1523\/JNEUROSCI.20-01-00251.2000","volume":"20","author":"M Noda","year":"2000","unstructured":"Noda M, Nakanishi H, Nabekura J, Akaike N. AMPA\u2013kainate subtypes of glutamate receptor in rat cerebral microglia. J Neurosci. 2000;20:251\u20138. \n                              https:\/\/doi.org\/10.1523\/JNEUROSCI.20-01-00251.2000\n                              \n                           .","journal-title":"J Neurosci"},{"key":"1539_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1474-9728.2004.00101.x","volume":"3","author":"I Blasko","year":"2004","unstructured":"Blasko I, Stampfer-Kountchev M, Robatscher P, Veerhuis R, Eikelenboom P, Grubeck-Loebenstein B. How chronic inflammation can affect the brain and support the development of Alzheimer\u2019s disease in old age: the role of microglia and astrocytes. Aging Cell. 2004;3:169\u201376. \n                              https:\/\/doi.org\/10.1111\/j.1474-9728.2004.00101.x\n                              \n                           .","journal-title":"Aging Cell"},{"key":"1539_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/emm.2006.40","volume":"38","author":"YS Kim","year":"2006","unstructured":"Kim YS, Joh TH. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp Mol Med. 2006;38:333. \n                              https:\/\/doi.org\/10.1038\/emm.2006.40\n                              \n                           .","journal-title":"Exp Mol Med"},{"key":"1539_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.nbd.2009.10.005","volume":"37","author":"D Papadimitriou","year":"2010","unstructured":"Papadimitriou D, Le Verche V, Jacquier A, Ikiz B, Przedborski S, Re DB. Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol Dis. 2010;37:493\u2013502. \n                              https:\/\/doi.org\/10.1016\/j.nbd.2009.10.005\n                              \n                           .","journal-title":"Neurobiol Dis"},{"key":"1539_CR17","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awp070","volume":"132","author":"JM Frischer","year":"2009","unstructured":"Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009;132:1175\u201389. \n                              https:\/\/doi.org\/10.1093\/brain\/awp070\n                              \n                           .","journal-title":"Brain"},{"key":"1539_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bbi.2019.01.026","volume":"79","author":"Kristoffer S\u00f8lvsten Burgdorf","year":"2019","unstructured":"Burgdorf KS, Trabjerg BB, Pedersen MG, Nissen J, Banasik K, Pedersen OB, et al. Large-scale study of Toxoplasma and Cytomegalovirus shows an association between infection and serious psychiatric disorders. Brain Behav Immun. 2019. \n                              https:\/\/doi.org\/10.1016\/j.bbi.2019.01.026\n                              \n                           .","journal-title":"Brain, Behavior, and Immunity"},{"key":"1539_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/pim.12157","volume":"37","author":"A Parlog","year":"2015","unstructured":"Parlog A, Schl\u00fcter D, Dunay IR. Toxoplasma gondii-induced neuronal alterations. Parasite Immunol. 2015;37:159\u201370. \n                              https:\/\/doi.org\/10.1111\/pim.12157\n                              \n                           .","journal-title":"Parasite Immunol"},{"key":"1539_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","volume":"39","author":"LM Weiss","year":"2009","unstructured":"Weiss LM, Dubey JP. Toxoplasmosis: a history of clinical observations. Int J Parasitol. 2009;39:895\u2013901. \n                              https:\/\/doi.org\/10.1016\/j.ijpara.2009.02.004\n                              \n                           .","journal-title":"Int J Parasitol"},{"key":"1539_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1742-2094-5-48","volume":"5","author":"G Hermes","year":"2008","unstructured":"Hermes G, Ajioka JW, Kelly KA, Mui E, Roberts F, Kasza K, et al. Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation. 2008;5:48. \n                              https:\/\/doi.org\/10.1186\/1742-2094-5-48\n                              \n                           .","journal-title":"J Neuroinflammation"},{"key":"1539_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/pim.12173","volume":"37","author":"N Blanchard","year":"2015","unstructured":"Blanchard N, Dunay IR, Schl\u00fcter D. Persistence of Toxoplasma gondii in the central nervous system: a fine-tuned balance between the parasite, the brain and the immune system. Parasite Immunol. 2015;37:150\u20138. \n                              https:\/\/doi.org\/10.1111\/pim.12173\n                              \n                           .","journal-title":"Parasite Immunol"},{"issue":"7","key":"1539_CR23","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.4049\/jimmunol.1402037","volume":"194","author":"Aindrila Biswas","year":"2015","unstructured":"Biswas A, Bruder D, Wolf SA, Jeron A, Mack M, Heimesaat MM, Dunay IR. Ly6Chigh monocytes control cerebral toxoplasmosis. J Immunol. 2015;1402037. \n                              https:\/\/doi.org\/10.4049\/jimmunol.1402037\n                              \n                           .","journal-title":"The Journal of Immunology"},{"key":"1539_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fcimb.2017.00259","volume":"7","author":"A Biswas","year":"2017","unstructured":"Biswas A, French T, D\u00fcsedau HP, Mueller N, Riek-Burchardt M, Dudeck A, et al. Behavior of neutrophil granulocytes during toxoplasma gondii infection in the central nervous system. Front Cell Infect Microbiol. 2017;7:259. \n                              https:\/\/doi.org\/10.3389\/fcimb.2017.00259\n                              \n                           .","journal-title":"Front Cell Infect Microbiol"},{"key":"1539_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003449","volume":"9","author":"V Feliu","year":"2013","unstructured":"Feliu V, Vasseur V, Grover HS, Chu HH, Brown MJ, Wang J, et al. Location of the CD8 T cell epitope within the antigenic precursor determines immunogenicity and protection against the Toxoplasma gondii parasite. PLoS Pathog. 2013;9:e1003449. \n                              https:\/\/doi.org\/10.1371\/journal.ppat.1003449\n                              \n                           .","journal-title":"PLoS Pathog"},{"key":"1539_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","volume":"157","author":"CSN Klose","year":"2014","unstructured":"Klose CSN, Flach M, M\u00f6hle L, Rogell L, Hoyler T, Ebert K, et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell. 2014;157:340\u201356. \n                              https:\/\/doi.org\/10.1016\/j.cell.2014.03.030\n                              \n                           .","journal-title":"Cell"},{"issue":"2","key":"1539_CR27","doi-asserted-by":"publisher","first-page":"e12516","DOI":"10.1111\/pim.12516","volume":"40","author":"I. R. Dunay","year":"2018","unstructured":"Dunay IR, Diefenbach A. Group 1 innate lymphoid cells in Toxoplasma gondii infection. Parasite Immunol. 2018. \n                              https:\/\/doi.org\/10.1111\/pim.12516\n                              \n                           .","journal-title":"Parasite Immunology"},{"key":"1539_CR28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1128\/MMBR.00027-15","volume":"79","author":"KJ Pittman","year":"2015","unstructured":"Pittman KJ, Knoll LJ. Long-term relationships: the complicated interplay between the host and the developmental stages of Toxoplasma gondii during acute and chronic infections. Microbiol Mol Biol Rev. 2015;79:387\u2013401. \n                              https:\/\/doi.org\/10.1128\/MMBR.00027-15\n                              \n                           .","journal-title":"Microbiol Mol Biol Rev"},{"key":"1539_CR29","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1073\/pnas.0608310104","volume":"104","author":"A Vyas","year":"2007","unstructured":"Vyas A, Kim S-K, Giacomini N, Boothroyd JC, Sapolsky RM. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. PNAS. 2007;104:6442\u20137. \n                              https:\/\/doi.org\/10.1073\/pnas.0608310104\n                              \n                           .","journal-title":"PNAS"},{"key":"1539_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1556\/1886.2017.00033","volume":"7","author":"C Alvarado-Esquivel","year":"2017","unstructured":"Alvarado-Esquivel C, Rico-Almochantaf YDR, Hern\u00e1ndez-Tinoco J, Qui\u00f1ones-Canales G, S\u00e1nchez-Anguiano LF, Torres-Gonz\u00e1lez J, et al. Toxoplasma gondii exposure and neurological disorders: an age- and gender-matched case-control pilot study. Eur J Microbiol Immunol (Bp). 2017;7:303\u20139. \n                              https:\/\/doi.org\/10.1556\/1886.2017.00033\n                              \n                           .","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"1539_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neulet.2010.03.057","volume":"475","author":"O Miman","year":"2010","unstructured":"Miman O, Kusbeci OY, Aktepe OC, Cetinkaya Z. The probable relation between Toxoplasma gondii and Parkinson\u2019s disease. Neurosci Lett. 2010;475:129\u201331. \n                              https:\/\/doi.org\/10.1016\/j.neulet.2010.03.057\n                              \n                           .","journal-title":"Neurosci Lett"},{"key":"1539_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WAD.0b013e3181f73bc2","volume":"25","author":"OY Kusbeci","year":"2011","unstructured":"Kusbeci OY, Miman O, Yaman M, Aktepe OC, Yazar S. Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord. 2011;25:1\u20133. \n                              https:\/\/doi.org\/10.1097\/WAD.0b013e3181f73bc2\n                              \n                           .","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1539_CR33","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3201\/eid0911.030143","volume":"9","author":"EF Torrey","year":"2003","unstructured":"Torrey EF, Yolken RH. Toxoplasma gondii and schizophrenia. Emerg Infect Dis. 2003;9:1375\u201380. \n                              https:\/\/doi.org\/10.3201\/eid0911.030143\n                              \n                           .","journal-title":"Emerg Infect Dis"},{"key":"1539_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1242\/dmm.014183","volume":"7","author":"A Parlog","year":"2014","unstructured":"Parlog A, Harsan L-A, Zagrebelsky M, Weller M, von Elverfeldt D, Mawrin C, et al. Chronic murine toxoplasmosis is defined by subtle changes in neuronal connectivity. Dis Model Mech. 2014;7:459\u201369. \n                              https:\/\/doi.org\/10.1242\/dmm.014183\n                              \n                           .","journal-title":"Dis Model Mech"},{"key":"1539_CR35","doi-asserted-by":"publisher","unstructured":"Lang D, Schott BH, van Ham M, Morton L, Kulikovskaja L, Herrera-Molina R, et al. Chronic Toxoplasma infection is associated with distinct alterations in the synaptic protein composition. J Neuroinflammation. 2018. \n                              https:\/\/doi.org\/10.1186\/s12974-018-1242-1\n                              \n                           .","DOI":"10.1186\/s12974-018-1242-1"},{"key":"1539_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1001\/jama.1955.02960060017005","volume":"158","author":"AJ Bollet","year":"1955","unstructured":"Bollet AJ, Black R, Bunim JJ. Major undesirable side-effects resulting from prednisolone and prednisone. JAMA. 1955;158:459\u201363. \n                              https:\/\/doi.org\/10.1001\/jama.1955.02960060017005\n                              \n                           .","journal-title":"JAMA"},{"key":"1539_CR37","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1212\/WNL.63.11_suppl_5.S35","volume":"63","author":"A Langer-Gould","year":"2004","unstructured":"Langer-Gould A, Moses HH, Murray TJ. Strategies for managing the side effects of treatments for multiple sclerosis. Neurology. 2004;63:S35\u201341. \n                              https:\/\/doi.org\/10.1212\/WNL.63.11_suppl_5.S35\n                              \n                           .","journal-title":"Neurology"},{"key":"1539_CR38","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/clinids\/8.6.1001","volume":"8","author":"J Mills","year":"1986","unstructured":"Mills J. Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS. Rev Infect Dis. 1986;8:1001\u201311. \n                              https:\/\/doi.org\/10.1093\/clinids\/8.6.1001\n                              \n                           .","journal-title":"Rev Infect Dis"},{"key":"1539_CR39","doi-asserted-by":"publisher","first-page":"e00057","DOI":"10.1128\/CMR.00057-17","volume":"31","author":"IR Dunay","year":"2018","unstructured":"Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev. 2018;31:e00057\u201317. \n                              https:\/\/doi.org\/10.1128\/CMR.00057-17\n                              \n                           .","journal-title":"Clin Microbiol Rev"},{"key":"1539_CR40","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.nurt.2007.08.002","volume":"4","author":"MS Weber","year":"2007","unstructured":"Weber MS, Hohlfeld R, Zamvil SS. Mechanism of action of glatiramer acetate in treatment of multiple sclerosis. Neurotherapeutics. 2007;4:647\u201353. \n                              https:\/\/doi.org\/10.1016\/j.nurt.2007.08.002\n                              \n                           .","journal-title":"Neurotherapeutics"},{"key":"1539_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nm.4022","volume":"22","author":"K Baruch","year":"2016","unstructured":"Baruch K, Deczkowska A, Rosenzweig N, Tsitsou-Kampeli A, Sharif AM, Matcovitch-Natan O, et al. PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease. Nat Med. 2016;22:135. \n                              https:\/\/doi.org\/10.1038\/nm.4022\n                              \n                           .","journal-title":"Nat Med"},{"key":"1539_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/intimm\/dxu096","volume":"27","author":"N Schwab","year":"2015","unstructured":"Schwab N, Schneider-Hohendorf T, Wiendl H. Therapeutic uses of anti-\u03b14-integrin (anti-VLA-4) antibodies in multiple sclerosis. Int Immunol. 2015;27:47\u201353. \n                              https:\/\/doi.org\/10.1093\/intimm\/dxu096\n                              \n                           .","journal-title":"Int Immunol"},{"key":"1539_CR43","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3389\/fimmu.2018.00850","volume":"9","author":"RM Eichenberger","year":"2018","unstructured":"Eichenberger RM, Ryan S, Jones L, Buitrago G, Polster R, Montes de Oca M, et al. Hookworm secreted extracellular vesicles interact with host cells and prevent inducible colitis in mice. Front Immunol. 2018;9:850. \n                              https:\/\/doi.org\/10.3389\/fimmu.2018.00850\n                              \n                           .","journal-title":"Front Immunol"},{"key":"1539_CR44","doi-asserted-by":"publisher","first-page":"40814","DOI":"10.1038\/srep40814","volume":"7","author":"C Terrazas","year":"2017","unstructured":"Terrazas C, de Dios Ruiz-Rosado J, Amici SA, Jablonski KA, Martinez-Saucedo D, Webb LM, et al. Helminth-induced Ly6C(hi) monocyte-derived alternatively activated macrophages suppress experimental autoimmune encephalomyelitis. Sci Rep. 2017;7:40814. \n                              https:\/\/doi.org\/10.1038\/srep40814\n                              \n                           .","journal-title":"Sci Rep"},{"key":"1539_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijpara.2012.11.011","volume":"43","author":"HJ McSorley","year":"2013","unstructured":"McSorley HJ, Hewitson JP, Maizels RM. Immunomodulation by helminth parasites: defining mechanisms and mediators. Int J Parasitol. 2013;43:301\u201310. \n                              https:\/\/doi.org\/10.1016\/j.ijpara.2012.11.011\n                              \n                           .","journal-title":"Int J Parasitol"},{"key":"1539_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijpara.2012.10.016","volume":"43","author":"JV Weinstock","year":"2013","unstructured":"Weinstock JV, Elliott DE. Translatability of helminth therapy in inflammatory bowel diseases. Int J Parasitol. 2013;43:245\u201351. \n                              https:\/\/doi.org\/10.1016\/j.ijpara.2012.10.016\n                              \n                           .","journal-title":"Int J Parasitol"},{"key":"1539_CR47","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/mt.2014.125","volume":"22","author":"RA Whelan","year":"2014","unstructured":"Whelan RA, Rausch S, Ebner F, G\u00fcnzel D, Richter JF, Hering NA, et al. A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation. Mol Ther. 2014;22:1730\u201340. \n                              https:\/\/doi.org\/10.1038\/mt.2014.125\n                              \n                           .","journal-title":"Mol Ther"},{"key":"1539_CR48","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1177\/1352458511398054","volume":"17","author":"JO Fleming","year":"2011","unstructured":"Fleming JO, Isaak A, Lee JE, Luzzio CC, Carrithers MD, Cook TD, et al. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler. 2011;17:743\u201354. \n                              https:\/\/doi.org\/10.1177\/1352458511398054\n                              \n                           .","journal-title":"Mult Scler"},{"key":"1539_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/1352458517736377","volume":"25","author":"J Fleming","year":"2019","unstructured":"Fleming J, Hernandez G, Hartman L, Maksimovic J, Nace S, Lawler B, et al. Safety and efficacy of helminth treatment in relapsing-remitting multiple sclerosis: results of the HINT 2 clinical trial. Mult Scler. 2019;25:81\u201391. \n                              https:\/\/doi.org\/10.1177\/1352458517736377\n                              \n                           .","journal-title":"Mult Scler"},{"key":"1539_CR50","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.immuni.2018.10.016","volume":"49","author":"RM Maizels","year":"2018","unstructured":"Maizels RM, Smits HH, McSorley HJ. Modulation of host immunity by helminths: the expanding repertoire of parasite effector molecules. Immunity. 2018;49:801\u201318. \n                              https:\/\/doi.org\/10.1016\/j.immuni.2018.10.016\n                              \n                           .","journal-title":"Immunity"},{"key":"1539_CR51","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.4049\/jimmunol.180.6.4265","volume":"180","author":"C Schnoeller","year":"2008","unstructured":"Schnoeller C, Rausch S, Pillai S, Avagyan A, Wittig BM, Loddenkemper C, et al. A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol. 2008;180:4265\u201372. \n                              https:\/\/doi.org\/10.4049\/jimmunol.180.6.4265\n                              \n                           .","journal-title":"J Immunol"},{"key":"1539_CR52","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1111\/all.12496","volume":"69","author":"F Ebner","year":"2014","unstructured":"Ebner F, Hepworth MR, Rausch S, Janek K, Niewienda A, K\u00fchl A, et al. Therapeutic potential of larval excretory\/secretory proteins of the pig whipworm Trichuris suis in allergic disease. Allergy. 2014;69:1489\u201397. \n                              https:\/\/doi.org\/10.1111\/all.12496\n                              \n                           .","journal-title":"Allergy"},{"key":"1539_CR53","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.4049\/jimmunol.1401217","volume":"194","author":"T Ziegler","year":"2015","unstructured":"Ziegler T, Rausch S, Steinfelder S, Klotz C, Hepworth MR, K\u00fchl AA, et al. A novel regulatory macrophage induced by a helminth molecule instructs IL-10 in CD4+ T cells and protects against mucosal inflammation. J Immunol. 2015;194:1555\u201364. \n                              https:\/\/doi.org\/10.4049\/jimmunol.1401217\n                              \n                           .","journal-title":"J Immunol"},{"key":"1539_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/cei.12252","volume":"177","author":"MA Pineda","year":"2014","unstructured":"Pineda MA, Al-Riyami L, Harnett W, Harnett MM. Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis. Clin Exp Immunol. 2014;177:13\u201323. \n                              https:\/\/doi.org\/10.1111\/cei.12252\n                              \n                           .","journal-title":"Clin Exp Immunol"},{"key":"1539_CR55","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1128\/IAI.00664-06","volume":"75","author":"KA Saunders","year":"2007","unstructured":"Saunders KA, Raine T, Cooke A, Lawrence CE. Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun. 2007;75:397\u2013407. \n                              https:\/\/doi.org\/10.1128\/IAI.00664-06\n                              \n                           .","journal-title":"Infect Immun"},{"key":"1539_CR56","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fimmu.2017.00453","volume":"8","author":"TB Smallwood","year":"2017","unstructured":"Smallwood TB, Giacomin PR, Loukas A, Mulvenna JP, Clark RJ, Miles JJ. Helminth immunomodulation in autoimmune disease. Front Immunol. 2017;8:453. \n                              https:\/\/doi.org\/10.3389\/fimmu.2017.00453\n                              \n                           .","journal-title":"Front Immunol"},{"key":"1539_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001248","volume":"7","author":"C Klotz","year":"2011","unstructured":"Klotz C, Ziegler T, Figueiredo AS, Rausch S, Hepworth MR, Obsivac N, et al. A helminth immunomodulator exploits host signaling events to regulate cytokine production in macrophages. PLoS Pathog. 2011;7:e1001248. \n                              https:\/\/doi.org\/10.1371\/journal.ppat.1001248\n                              \n                           .","journal-title":"PLoS Pathog"},{"key":"1539_CR58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12865-015-0074-3","volume":"16","author":"H Helmby","year":"2015","unstructured":"Helmby H. Human helminth therapy to treat inflammatory disorders - where do we stand? BMC Immunol. 2015;16:12. \n                              https:\/\/doi.org\/10.1186\/s12865-015-0074-3\n                              \n                           .","journal-title":"BMC Immunol"},{"key":"1539_CR59","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.pt.2018.05.011","volume":"34","author":"J Kahl","year":"2018","unstructured":"Kahl J, Brattig N, Liebau E. The untapped pharmacopeic potential of helminths. Trends Parasitol. 2018;34:828\u201342. \n                              https:\/\/doi.org\/10.1016\/j.pt.2018.05.011\n                              \n                           .","journal-title":"Trends Parasitol"},{"key":"1539_CR60","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1128\/IAI.01236-07","volume":"76","author":"IA Khan","year":"2008","unstructured":"Khan IA, Hakak R, Eberle K, Sayles P, Weiss LM, Urban JF. Coinfection with Heligmosomoides polygyrus fails to establish CD8+ T-cell immunity against Toxoplasma gondii. Infect Immun. 2008;76:1305\u201313. \n                              https:\/\/doi.org\/10.1128\/IAI.01236-07\n                              \n                           .","journal-title":"Infect Immun"},{"key":"1539_CR61","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00281-012-0347-3","volume":"34","author":"LA Reynolds","year":"2012","unstructured":"Reynolds LA, Filbey KJ, Maizels RM. Immunity to the model intestinal helminth parasite Heligmosomoides polygyrus. Semin Immunopathol. 2012;34:829\u201346. \n                              https:\/\/doi.org\/10.1007\/s00281-012-0347-3\n                              \n                           .","journal-title":"Semin Immunopathol"},{"key":"1539_CR62","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1128\/IAI.01233-07","volume":"76","author":"S Rausch","year":"2008","unstructured":"Rausch S, Huehn J, Kirchhoff D, Rzepecka J, Schnoeller C, Pillai S, et al. Functional analysis of effector and regulatory T cells in a parasitic nematode infection. Infect Immun. 2008;76:1908\u201319. \n                              https:\/\/doi.org\/10.1128\/IAI.01233-07\n                              \n                           .","journal-title":"Infect Immun"},{"key":"1539_CR63","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1128\/AAC.48.12.4848-4854.2004","volume":"48","author":"IR Dunay","year":"2004","unstructured":"Dunay IR, Heimesaat MM, Bushrab FN, M\u00fcller RH, Stocker H, Arasteh K, et al. Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Antimicrob Agents Chemother. 2004;48:4848\u201354. \n                              https:\/\/doi.org\/10.1128\/AAC.48.12.4848-4854.2004\n                              \n                           .","journal-title":"Antimicrob Agents Chemother"},{"key":"1539_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004994","volume":"11","author":"SM Coomes","year":"2015","unstructured":"Coomes SM, Pelly VS, Kannan Y, Okoye IS, Czieso S, Entwistle LJ, et al. IFN\u03b3 and IL-12 restrict Th2 responses during helminth\/plasmodium co-infection and promote IFN\u03b3 from Th2 cells. PLoS Pathog. 2015;11:e1004994. \n                              https:\/\/doi.org\/10.1371\/journal.ppat.1004994\n                              \n                           .","journal-title":"PLoS Pathog"},{"key":"1539_CR65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40478-016-0293-8","volume":"4","author":"L M\u00f6hle","year":"2016","unstructured":"M\u00f6hle L, Israel N, Paarmann K, Krohn M, Pietkiewicz S, M\u00fcller A, et al. Chronic Toxoplasma gondii infection enhances \u03b2-amyloid phagocytosis and clearance by recruited monocytes. Acta Neuropathol Commun. 2016;4:25. \n                              https:\/\/doi.org\/10.1186\/s40478-016-0293-8\n                              \n                           .","journal-title":"Acta Neuropathol Commun"},{"key":"1539_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/glia.23553","volume":"67","author":"HP D\u00fcsedau","year":"2019","unstructured":"D\u00fcsedau HP, Kleveman J, Figueiredo CA, Biswas A, Steffen J, Kliche S, et al. p75NTR regulates brain mononuclear cell function and neuronal structure in Toxoplasma infection-induced neuroinflammation. Glia. 2019;67:193\u2013211. \n                              https:\/\/doi.org\/10.1002\/glia.23553\n                              \n                           .","journal-title":"Glia"},{"issue":"1","key":"1539_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1757-4749-6-19","volume":"6","author":"Stefan Bereswill","year":"2014","unstructured":"Bereswill S, K\u00fchl AA, Alutis M, Fischer A, M\u00f6hle L, Struck D, et al. The impact of Toll-like-receptor-9 on intestinal microbiota composition and extraintestinal sequelae in experimental Toxoplasma gondii induced ileitis. Gut Pathog. 2014;6:19. \n                              https:\/\/doi.org\/10.1186\/1757-4749-6-19\n                              \n                           .","journal-title":"Gut Pathogens"},{"key":"1539_CR68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1556\/EuJMI.4.2014.1.6","volume":"4","author":"L M\u00f6hle","year":"2014","unstructured":"M\u00f6hle L, Parlog A, Pahnke J, Dunay IR. Spinal cord pathology in chronic experimental Toxoplasma gondii infection. Eur J Microbiol Immunol (Bp). 2014;4:65\u201375. \n                              https:\/\/doi.org\/10.1556\/EuJMI.4.2014.1.6\n                              \n                           .","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"1539_CR69","doi-asserted-by":"publisher","first-page":"628","DOI":"10.4049\/jimmunol.165.2.628","volume":"165","author":"G Yap","year":"2000","unstructured":"Yap G, Pesin M, Sher A. Cutting edge: IL-12 is required for the maintenance of IFN-\u03b3 production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J Immunol. 2000;165:628\u201331. \n                              https:\/\/doi.org\/10.4049\/jimmunol.165.2.628\n                              \n                           .","journal-title":"J Immunol"},{"key":"1539_CR70","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.pt.2011.08.001","volume":"27","author":"MB Melo","year":"2011","unstructured":"Melo MB, Jensen KDC, Saeij JPJ. Toxoplasma gondii effectors are master regulators of the inflammatory response. Trends Parasitol. 2011;27:487\u201395. \n                              https:\/\/doi.org\/10.1016\/j.pt.2011.08.001\n                              \n                           .","journal-title":"Trends Parasitol"},{"key":"1539_CR71","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.chom.2011.05.010","volume":"9","author":"PJ Murray","year":"2011","unstructured":"Murray PJ. Macrophages as a battleground for toxoplasma pathogenesis. Cell Host Microbe. 2011;9:445\u20137. \n                              https:\/\/doi.org\/10.1016\/j.chom.2011.05.010\n                              \n                           .","journal-title":"Cell Host Microbe"},{"key":"1539_CR72","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/eji.201646632","volume":"47","author":"A Cossarizza","year":"2017","unstructured":"Cossarizza A, Chang H-D, Radbruch A, Akdis M, Andr\u00e4 I, Annunziato F, et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies. Eur J Immunol. 2017;47:1584\u2013797. \n                              https:\/\/doi.org\/10.1002\/eji.201646632\n                              \n                           .","journal-title":"Eur J Immunol"},{"key":"1539_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005643","volume":"12","author":"CN David","year":"2016","unstructured":"David CN, Frias ES, Szu JI, Vieira PA, Hubbard JA, Lovelace J, et al. GLT-1-dependent disruption of CNS glutamate homeostasis and neuronal function by the protozoan parasite Toxoplasma gondii. PLoS Pathog. 2016;12:e1005643. \n                              https:\/\/doi.org\/10.1371\/journal.ppat.1005643\n                              \n                           .","journal-title":"PLoS Pathog"},{"key":"1539_CR74","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1515\/revneuro-2015-0072","volume":"27","author":"N Itoh","year":"2016","unstructured":"Itoh N, Enomoto A, Nagai T, Takahashi M, Yamada K. Molecular mechanism linking BDNF\/TrkB signaling with the NMDA receptor in memory: the role of Girdin in the CNS. Rev Neurosci. 2016;27:481\u201390. \n                              https:\/\/doi.org\/10.1515\/revneuro-2015-0072\n                              \n                           .","journal-title":"Rev Neurosci"},{"issue":"Pt C","key":"1539_CR75","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.neuropharm.2013.04.024","volume":"76","author":"P Bekinschtein","year":"2014","unstructured":"Bekinschtein P, Cammarota M, Medina JH. BDNF and memory processing. Neuropharmacology. 2014;76(Pt C):677\u201383. \n                              https:\/\/doi.org\/10.1016\/j.neuropharm.2013.04.024\n                              \n                           .","journal-title":"Neuropharmacology"},{"key":"1539_CR76","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965\u201376. \n                              https:\/\/doi.org\/10.1016\/S0140-6736(04)16412-X\n                              \n                           .","journal-title":"Lancet"},{"key":"1539_CR77","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1084\/jem.189.5.803","volume":"189","author":"T Sch\u00fcler","year":"1999","unstructured":"Sch\u00fcler T, Qin Z, Ibe S, Noben-Trauth N, Blankenstein T. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. J Exp Med. 1999;189:803\u201310. \n                              https:\/\/doi.org\/10.1084\/jem.189.5.803\n                              \n                           .","journal-title":"J Exp Med"},{"key":"1539_CR78","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.187.3.307","volume":"187","author":"A Mencacci","year":"1998","unstructured":"Mencacci A, Del Sero G, Cenci E, d'Ostiani CF, Bacci A, Montagnoli C, et al. Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J Exp Med. 1998;187:307\u201317. \n                              https:\/\/doi.org\/10.1084\/jem.187.3.307\n                              \n                           .","journal-title":"J Exp Med"},{"key":"1539_CR79","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1084\/jem.194.12.1767","volume":"194","author":"T Sch\u00fcler","year":"2001","unstructured":"Sch\u00fcler T, Kammertoens T, Preiss S, Debs P, Noben-Trauth N, Blankenstein T. Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8(+) T cells. J Exp Med. 2001;194:1767\u201375. \n                              https:\/\/doi.org\/10.1084\/jem.194.12.1767\n                              \n                           .","journal-title":"J Exp Med"},{"key":"1539_CR80","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4049\/jimmunol.1601741","volume":"198","author":"A Marple","year":"2017","unstructured":"Marple A, Wu W, Shah S, Zhao Y, Du P, Gause WC, Yap GS. Cutting edge: helminth coinfection blocks effector differentiation of CD8 T cells through alternate host Th2- and IL-10-mediated responses. J Immunol. 2017;198:634\u20139. \n                              https:\/\/doi.org\/10.4049\/jimmunol.1601741\n                              \n                           .","journal-title":"J Immunol"},{"key":"1539_CR81","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1128\/IAI.72.7.3812-3822.2004","volume":"72","author":"O Liesenfeld","year":"2004","unstructured":"Liesenfeld O, Dunay IR, Erb KJ. Infection with Toxoplasma gondii reduces established and developing Th2 responses induced by Nippostrongylus brasiliensis infection. Infect Immun. 2004;72:3812\u201322. \n                              https:\/\/doi.org\/10.1128\/IAI.72.7.3812-3822.2004\n                              \n                           .","journal-title":"Infect Immun"},{"key":"1539_CR82","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3389\/fcimb.2017.00341","volume":"7","author":"N Ahmed","year":"2017","unstructured":"Ahmed N, French T, Rausch S, Kuhl A, Hemminger K, Dunay IR, et al. Toxoplasma co-infection prevents Th2 differentiation and leads to a helminth-specific Th1 response. Front Cell Infect Microbiol. 2017;7:341. \n                              https:\/\/doi.org\/10.3389\/fcimb.2017.00341\n                              \n                           .","journal-title":"Front Cell Infect Microbiol"},{"key":"1539_CR83","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbi.2010.10.015","volume":"25","author":"R Yirmiya","year":"2011","unstructured":"Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun. 2011;25:181\u2013213. \n                              https:\/\/doi.org\/10.1016\/j.bbi.2010.10.015\n                              \n                           .","journal-title":"Brain Behav Immun"},{"key":"1539_CR84","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/nature04671","volume":"440","author":"D Stellwagen","year":"2006","unstructured":"Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-\u03b1. Nature. 2006;440:1054. \n                              https:\/\/doi.org\/10.1038\/nature04671\n                              \n                           .","journal-title":"Nature"},{"key":"1539_CR85","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1523\/JNEUROSCI.21-17-06480.2001","volume":"21","author":"A Bal-Price","year":"2001","unstructured":"Bal-Price A, Brown GC. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci. 2001;21:6480\u201391.","journal-title":"J Neurosci"},{"key":"1539_CR86","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ncpneuro0355","volume":"2","author":"NJ Maragakis","year":"2006","unstructured":"Maragakis NJ, Rothstein JD. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Rev Neurol. 2006;2:679. \n                              https:\/\/doi.org\/10.1038\/ncpneuro0355\n                              \n                           .","journal-title":"Nat Rev Neurol"},{"key":"1539_CR87","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11064-012-0708-2","volume":"37","author":"JS Rao","year":"2012","unstructured":"Rao JS, Kellom M, Kim H-W, Rapoport SI, Reese EA. Neuroinflammation and synaptic loss. Neurochem Res. 2012;37:903\u201310. \n                              https:\/\/doi.org\/10.1007\/s11064-012-0708-2\n                              \n                           .","journal-title":"Neurochem Res"},{"key":"1539_CR88","doi-asserted-by":"publisher","first-page":"e01428","DOI":"10.1128\/mBio.01428-15","volume":"6","author":"JM Brooks","year":"2015","unstructured":"Brooks JM, Carrillo GL, Su J, Lindsay DS, Fox MA, Blader IJ. Toxoplasma gondii infections alter GABAergic synapses and signaling in the central nervous system. MBio. 2015;6:e01428\u201315. \n                              https:\/\/doi.org\/10.1128\/mBio.01428-15\n                              \n                           .","journal-title":"MBio"},{"issue":"10","key":"1539_CR89","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1073\/pnas.1813562116","volume":"116","author":"Thuy-Truc Ta","year":"2019","unstructured":"Ta T-T, Dikmen HO, Schilling S, Chausse B, Lewen A, Hollnagel J-O, Kann O. Priming of microglia with IFN-\u03b3 slows neuronal gamma oscillations in situ. Proc Natl Acad Sci U S A. 2019. \n                              https:\/\/doi.org\/10.1073\/pnas.1813562116\n                              \n                           .","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"1539_CR90","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.immuni.2018.04.016","volume":"48","author":"F Filipello","year":"2018","unstructured":"Filipello F, Morini R, Corradini I, Zerbi V, Canzi A, Michalski B, et al. The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity. Immunity. 2018;48:979\u2013991.e8. \n                              https:\/\/doi.org\/10.1016\/j.immuni.2018.04.016\n                              \n                           .","journal-title":"Immunity"},{"key":"1539_CR91","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.expneurol.2014.08.016","volume":"261","author":"L Garcia-Bonilla","year":"2014","unstructured":"Garcia-Bonilla L, Park L, Iadecola C. Commentary on Myers et al.: Growing role of the innate immunity receptor CD36 in central nervous system diseases. Exp Neurol. 2014;261:633\u20137. \n                              https:\/\/doi.org\/10.1016\/j.expneurol.2014.08.016\n                              \n                           .","journal-title":"Exp Neurol"},{"key":"1539_CR92","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-9-20","volume":"9","author":"JD Ulrich","year":"2014","unstructured":"Ulrich JD, Finn MB, Wang Y, Shen A, Mahan TE, Jiang H, et al. Altered microglial response to A\u03b2 plaques in APPPS1-21 mice heterozygous for TREM2. Mol Neurodegener. 2014;9:20. \n                              https:\/\/doi.org\/10.1186\/1750-1326-9-20\n                              \n                           .","journal-title":"Mol Neurodegener"},{"key":"1539_CR93","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer\u2019s disease mice. J Neurosci. 2008;28:8354\u201360. \n                              https:\/\/doi.org\/10.1523\/JNEUROSCI.0616-08.2008\n                              \n                           .","journal-title":"J Neurosci"},{"key":"1539_CR94","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.3128869","volume":"240","author":"Y Suzuki","year":"1988","unstructured":"Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988;240:516\u20138. \n                              https:\/\/doi.org\/10.1126\/science.3128869\n                              \n                           .","journal-title":"Science"},{"key":"1539_CR95","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ni.3656","volume":"18","author":"RS Klein","year":"2017","unstructured":"Klein RS, Garber C, Howard N. Infectious immunity in the central nervous system and brain function. Nat Immunol. 2017;18:132. \n                              https:\/\/doi.org\/10.1038\/ni.3656\n                              \n                           .","journal-title":"Nat Immunol"},{"key":"1539_CR96","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jad.2015.03.038","volume":"179","author":"N Hamdani","year":"2015","unstructured":"Hamdani N, Daban-Huard C, Lajnef M, Gadel R, Le Corvoisier P, Delavest M, et al. Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels. J Affect Disord. 2015;179:161\u20136. \n                              https:\/\/doi.org\/10.1016\/j.jad.2015.03.038\n                              \n                           .","journal-title":"J Affect Disord"},{"key":"1539_CR97","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.pt.2017.04.001","volume":"33","author":"EA Wohlfert","year":"2017","unstructured":"Wohlfert EA, Blader IJ, Wilson EH. Brains and brawn: toxoplasma infections of the central nervous system and skeletal muscle. Trends Parasitol. 2017;33:519\u201331. \n                              https:\/\/doi.org\/10.1016\/j.pt.2017.04.001\n                              \n                           .","journal-title":"Trends Parasitol"},{"key":"1539_CR98","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1128\/IAI.00217-16","volume":"84","author":"F Ihara","year":"2016","unstructured":"Ihara F, Nishimura M, Muroi Y, Mahmoud ME, Yokoyama N, Nagamune K, Nishikawa Y. Toxoplasma gondii infection in mice impairs long-term fear memory consolidation through dysfunction of the cortex and amygdala. Infect Immun. 2016;84:2861\u201370. \n                              https:\/\/doi.org\/10.1128\/IAI.00217-16\n                              \n                           .","journal-title":"Infect Immun"},{"key":"1539_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002825","volume":"8","author":"AA Koshy","year":"2012","unstructured":"Koshy AA, Dietrich HK, Christian DA, Melehani JH, Shastri AJ, Hunter CA, Boothroyd JC. Toxoplasma co-opts host cells it does not invade. PLoS Pathog. 2012;8:e1002825. \n                              https:\/\/doi.org\/10.1371\/journal.ppat.1002825\n                              \n                           .","journal-title":"PLoS Pathog"},{"key":"1539_CR100","doi-asserted-by":"publisher","first-page":"11496","DOI":"10.1038\/s41598-017-10675-6","volume":"7","author":"HM Ng\u00f4","year":"2017","unstructured":"Ng\u00f4 HM, Zhou Y, Lorenzi H, Wang K, Kim T-K, Zhou Y, et al. Toxoplasma modulates signature pathways of human epilepsy, neurodegeneration & cancer. Sci Rep. 2017;7:11496. \n                              https:\/\/doi.org\/10.1038\/s41598-017-10675-6\n                              \n                           .","journal-title":"Sci Rep"},{"key":"1539_CR101","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.bbi.2014.12.006","volume":"45","author":"A Mendy","year":"2015","unstructured":"Mendy A, Vieira ER, Albatineh AN, Gasana J. Immediate rather than delayed memory impairment in older adults with latent toxoplasmosis. Brain Behav Immun. 2015;45:36\u201340. \n                              https:\/\/doi.org\/10.1016\/j.bbi.2014.12.006\n                              \n                           .","journal-title":"Brain Behav Immun"},{"key":"1539_CR102","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/schbul\/sbs043","volume":"38","author":"EF Torrey","year":"2012","unstructured":"Torrey EF, Bartko JJ, Yolken RH. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull. 2012;38:642\u20137. \n                              https:\/\/doi.org\/10.1093\/schbul\/sbs043\n                              \n                           .","journal-title":"Schizophr Bull"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1539-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-019-1539-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1539-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T23:19:24Z","timestamp":1595891964000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-019-1539-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1539"],"URL":"https:\/\/doi.org\/10.1186\/s12974-019-1539-8","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]},"assertion":[{"value":"27 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the respective authorities (Landesverwaltungsamt Halle, Sachsen-Anhalt, Germany) in accordance with the German and European legislation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}